Meta goes ‘MAGA’: Facebook adjusts fact-checking approach as Zuckerberg touts ‘free expression’ and cites ‘cultural tipping point’
Read more at MarketWatch
-
No Fact-Checking and More Hate Speech: Meta Goes MAGA
Mark Zuckerberg has fully adopted the language of his former right-wing critics about what constitutes censorship.Wired - 2h -
Meta employees criticize Zuckerberg decisions to end fact-checking, add Dana White to board
Meta employees internally criticized the company's decision to end third-party fact-checking two weeks before President-elect Donald Trump's inauguration.CNBC - 17h -
Meta Ends Fact-Checking on Facebook, Instagram in Free-Speech Pitch
CEO Mark Zuckerberg, who has been building ties with the incoming Trump administration, said the move was an attempt to restore free expression on its platforms.The Wall Street Journal - 18h -
Do Facts Meta on Facebook?
Mark Zuckerberg removes fact-checking on his platforms.BBC News - 18h -
Jordan plans meeting with Zuckerberg after Meta eliminates fact-check program
Politico - 20h -
Mark Zuckerberg announces end of fact-checking program for Meta
Meta’s CEO Mark Zuckerberg announced in a video that its platforms, including Facebook and Instagram, will no longer implement a fact-checking policy, instead relying on community notes similar to ...NBC News - 1d -
Mark Zuckerberg sports $900,000 watch as he calls time on Meta fact-checking
Tech giant CEO wore Greubel Forsey ‘Hand Made 1’, which retails for $895,500, as he announced policy overhaul. Mark Zuckerberg wore a rare Swiss watch worth nearly $900,000 as he announced a ...The Guardian - 15h -
Some Meta employees criticize Zuckerberg decisions to end fact-checking, add Dana White to board
Meta employees took to their internal forum Tuesday, criticizing the company’s decision to end third-party fact-checking on its services two weeks before President-elect Donald Trump’s inauguration.NBC News - 16h -
Meta ending fact-checking program: Zuckerberg
Social media giant Meta announced a series of changes to its content moderation policies Tuesday, including the elimination of its fact-checking program, in what CEO Mark Zuckerberg said was an ...The Hill - 1d
More from MarketWatch
-
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.MarketWatch - 39m -
Cannabis companies say DEA has closed mind against a less-dangerous pot ranking
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.MarketWatch - 40m -
Jobless claims fall to a nearly one-year low as Trump set to take office
The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...MarketWatch - 46m -
Trump’s push for SALT tax reform threatened by hardline GOP budget hawks
The path of least resistance could be $5 trillion in new government debt.MarketWatch - 47m -
The market’s wobbling. Here are BlackRock’s shields for the biggest risks.
Here are the hedges the $11 trillion asset manager recommends for the concerns weighing on investor minds.MarketWatch - 55m
More in Business
-
Quantum stocks like Rigetti plunge after Nvidia's Huang says the computers are 15 to 30 years away
Quantum computing stocks dropped Wednesday after Nvidia CEO Jensen Huang declared that useful quantum computers are likely decades in the future.CNBC - 9m -
EU will defend borders, says French minister in response to Trump’s Greenland threats
European leaders also criticise Trump ally Elon Musk over support for far-right movementsFinancial Times - 19m -
My Junior Employee Sends Rude Emails
… and two other tricky workplace dilemmas.Inc. - 27m -
We're locking in roughly 100% gains on a stock that has fallen out of favor
The stock has been downgraded by three analysts this week.CNBC - 28m -
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.MarketWatch - 39m